Earnings Feed
Start Free
Home/Filings/4/0001104659-23-070300
4//SEC Filing

RAKIN KEVIN 4

Accession 0001104659-23-070300

CIK 0001708527other
View on SEC.govCompany Profile

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 3:32 PM ET

Size

23.7 KB

Accession

0001104659-23-070300

Insider Transaction Report

Form 4
Period: 2023-06-08
AZIYO BIOLOGICS, INC.AZYO
HighCape Capital, L.P.
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
HighCape Partners GP, L.P.
10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
HighCape Co-Investment Vehicle I, LLC
10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
HIGHCAPE PARTNERS QP, L.P.
10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
RAKIN KEVIN
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
HIGHCAPE PARTNERS, L.P.
10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
HighCape Partners GP, LLC
10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
HighCape Capital, LLC
10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
HighCape Co-Investment Vehicle II, LLC
10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
Zuga Matt
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-08+37,500→ 37,500 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (37,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-08+25,000→ 25,000 total(indirect: See footnote)
    Exercise: $2.37Exp: 2033-06-07→ Class A Common Stock (25,000 underlying)
Footnotes (3)
  • [F1]This option was granted automatically under the Issuer's First Amended and Restated Non-Employee Director Compensation Policy and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date.
  • [F2]Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors.
  • [F3]Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors.

Documents

1 file

Issuer

AZIYO BIOLOGICS, INC.

CIK 0001708527

→
Entity typeother

Related Parties

1
  • filerCIK 0001184421

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 3:32 PM ET
Size
23.7 KB
View on SEC.gov